Cytecare plans to open another 4-5 hospitals by the end of this year.

Cytecare has recently raised Rs 165 crore with the support of High Networth Individuals (HNIs) and expects to break even in the next three years, company officials told BusinessLine .

The hospital chain is co-founded by Ferzaan Engineer, former head of Quintiles Research India and Medwell Ventures, and Suresh Ramu. The venture is backed by several key doctors who have made investments individually.

The healthcare venture is about to open its first cancer-related speciality hospital in Bengaluru. This hospital will be a 150-bed facility, spread across 16,000 sq feet, and will begin operations in October.

Further, Cytecare hospitals have radiation bunkers, five operation theatres, and also have super specialists in pain management, Engineer said.

The hospital chain will provide facilities like diagnosis, personalised treatment, chemotherapy, radiology, counselling, pain management and palliative care. Incidences of cancer are on the rise in India and hospitals claim that a lot can be done when cases related to the disease can be detected early.

“By using technology, we can predict and target cancer in a better way,” said Engineer.

Other chains like HealthCare Global (HCG) Enterprises chain of cancer care hospitals have already embarked on this journey. HCG has partnered with Strand Life Sciences, a software and services development company for life sciences research, to set standards in cancer treatment and risk predictions, by using genomics-based diagnostics.

comment COMMENT NOW